EQS-Adhoc

    125 Aufrufe 125 0 Kommentare 0 Kommentare

    Comment on media report

    Für Sie zusammengefasst
    • Evotec received non-binding takeover interest from Halozyme.
    • Offer price proposed at EUR 11.00 per share.
    • Company to analyze and inform market on next steps.
    EQS-Adhoc - Comment on media report

    EQS-Ad-hoc: Evotec SE / Key word(s): Miscellaneous
    Comment on media report

    14-Nov-2024 / 22:51 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    Ad hoc: Comment on media report

    Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO)

    With respect to a media report, Evotec SE (“Company”) declares that it has received, without prior contact, a non-binding expression of interest from the listed US biotechnology company Halozyme Therapeutics Inc. regarding a takeover offer addressed to the shareholders of the Company with an offer price of EUR 11.00 per share. The Company will carefully analyze this expression of interest, decide on next steps, and inform the capital market in accordance with the legal requirements.

    – End of the ad hoc release –

    Contact: Volker Braun, EVP Head of Global Investor Relations & ESG, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49 (0) 151 1940 5058 (m), volker.braun@evotec.com



    End of Inside Information

    14-Nov-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: Evotec SE
    Manfred Eigen Campus / Essener Bogen 7
    22419 Hamburg
    Germany
    Phone: +49 (0)40 560 81-0
    Fax: +49 (0)40 560 81-222
    E-mail: info@evotec.com
    Internet: www.evotec.com
    ISIN: DE0005664809
    WKN: 566480
    Indices: SDAX, TecDAX
    Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Nasdaq
    EQS News ID: 2030647

     
    End of Announcement EQS News Service

    2030647  14-Nov-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=2030647&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e

    Evotec

    -4,01 %
    -2,19 %
    +5,71 %
    +43,13 %
    -53,81 %
    -78,95 %
    -58,85 %
    +154,99 %
    +236,55 %
    ISIN:DE0005664809WKN:566480


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Comment on media report EQS-Ad-hoc: Evotec SE / Key word(s): Miscellaneous Comment on media report 14-Nov-2024 / 22:51 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group …